Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (5MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-588865
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.58886
Zusammenfassung
Abstract Multiple types of oncolytic viruses are currently under investigation in clinical trials. To optimize therapeutic outcomes it is believed that the plethora of different tumor types will require a diversity of different virus types. Sendai virus (SeV), a murine parainfluenza virus, displays a broad host range, enters cells within minutes and already has been applied safely as a gene ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags